Literature DB >> 29399305

Fractionated CO2 Laser in the Treatment of Striae Alba in Darker Skinned Patients - A Prospective Study.

Zohreh Tehranchinia1, Alireza Mahboubianfar1, Hoda Rahimi1, Nazanin Saedi2.   

Abstract

Introduction: In recent years, the positive effect of fractional CO2 laser on increasing collagen fibers, and consequently its effect on treating striae has been suggested. The present study aims to assess the effectiveness of CO2 fractional laser 10600-nm in the treatment of striae alba.
Methods: In this prospective clinical trial, 2 treatment sessions of fractional CO2 laser with 4-week interval was given to 30 patients with striae alba. Cutaneous resonance running time (CRRT) was measured at baseline and at week 4 and 3 months after the last session of laser therapy. The level of improvement was assessed by 2 independent dermatologists and patients after 3 months of follow up.
Results: 16.7% of patients had moderate improvement, 63.3% had minimal improvement, and 20% had no improvement. A statistical significant difference was found in median CRRT during the study (P < 0.0001). The median CRRT levels were significantly higher in week 4 and 3 months after the last treatment compared to the baseline (both P < 0.001). Likewise, a significant increase was observed in median CRRT level from week 4 till the end of study (P < 0.001). Evaluation of participant satisfaction revealed that 10% were very satisfied, 10% satisfied, 3.3% slightly satisfied, and 76.7% unsatisfied.
Conclusion: Striae alba remain a challenging condition to treat. The treatment of striae alba with CO2 fractional laser results in minimal improvement with mild side effects.

Entities:  

Keywords:  Fractional laser; Non-ablative laser; Stretch mark; Striae

Year:  2017        PMID: 29399305      PMCID: PMC5775949          DOI: 10.15171/jlms.2018.04

Source DB:  PubMed          Journal:  J Lasers Med Sci        ISSN: 2008-9783


  38 in total

1.  The safety and efficacy of the 308-nm excimer laser for pigment correction of hypopigmented scars and striae alba.

Authors:  Macrene R Alexiades-Armenakas; Leonard J Bernstein; Paul M Friedman; Roy G Geronemus
Journal:  Arch Dermatol       Date:  2004-08

2.  Evaluation of a 1540-nm and a 1410-nm Nonablative Fractionated Laser for the Treatment of Striae.

Authors:  Krystle Wang; Nicholas Ross; Katie Osley; Joya Sahu; Nazanin Saedi
Journal:  Dermatol Surg       Date:  2016-02       Impact factor: 3.398

3.  Elastotic striae associated with striae distensae after application of very potent topical corticosteroids.

Authors:  S Neve; G Kirtschig
Journal:  Clin Exp Dermatol       Date:  2006-05       Impact factor: 3.470

Review 4.  Cushing's syndrome: update on signs, symptoms and biochemical screening.

Authors:  Lynnette K Nieman
Journal:  Eur J Endocrinol       Date:  2015-07-08       Impact factor: 6.664

Review 5.  Physiological skin changes during pregnancy.

Authors:  Kelly H Tyler
Journal:  Clin Obstet Gynecol       Date:  2015-03       Impact factor: 2.190

6.  Efficacy of pulsed dye laser versus intense pulsed light in the treatment of striae distensae.

Authors:  Hisham Shokeir; Ahmed El Bedewi; Safinaz Sayed; Ghada El Khalafawy
Journal:  Dermatol Surg       Date:  2014-06       Impact factor: 3.398

7.  Treatment of stretch marks with the 585-nm flashlamp-pumped pulsed dye laser.

Authors:  D H McDaniel; K Ash; M Zukowski
Journal:  Dermatol Surg       Date:  1996-04       Impact factor: 3.398

8.  Sodium L-ascorbate enhances elastic fibers deposition by fibroblasts from normal and pathologic human skin.

Authors:  Aleksander Hinek; Hyunjun J Kim; Yanting Wang; Andrew Wang; Thomas F Mitts
Journal:  J Dermatol Sci       Date:  2014-06-11       Impact factor: 4.563

9.  Treatment of Striae Distensae with Nonablative Fractional Laser versus Ablative CO(2) Fractional Laser: A Randomized Controlled Trial.

Authors:  You Jin Yang; Ga-Young Lee
Journal:  Ann Dermatol       Date:  2011-11-03       Impact factor: 1.444

Review 10.  Topical management of striae distensae (stretch marks): prevention and therapy of striae rubrae and albae.

Authors:  S Ud-Din; D McGeorge; A Bayat
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-10-20       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.